Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334M
-
Number of holders
-
283
-
Total 13F shares, excl. options
-
234M
-
Shares change
-
+898K
-
Total reported value, excl. options
-
$2.2B
-
Value change
-
+$19.3M
-
Put/Call ratio
-
0.45
-
Number of buys
-
138
-
Number of sells
-
-124
-
Price
-
$9.39
Significant Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q3 2024
348 filings reported holding IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock as of Q3 2024.
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) has 283 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 234M shares
of 334M outstanding shares and own 70.12% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (27.3M shares), PERCEPTIVE ADVISORS LLC (26.6M shares), MHR FUND MANAGEMENT LLC (24M shares), BlackRock, Inc. (21.5M shares), STATE STREET CORP (13.2M shares), Soleus Capital Management, L.P. (8.53M shares), Hood River Capital Management LLC (8.14M shares), T. Rowe Price Investment Management, Inc. (5.86M shares), GEODE CAPITAL MANAGEMENT, LLC (5.65M shares), and Artisan Partners Limited Partnership (4.8M shares).
This table shows the top 283 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.